✦ LIBER ✦

Reduced Intensity Allogeneic Hematopoietic Stem Cell Transplantation Can Achieve Both Disease Control And Very Good Outcomes In Elderly (>60) Patients With Hematologic Malignancies

✍ Scribed by G. Meyers; N. Subbiah; G. Palmbach; T. Kovacsovics; F. Abar; B. Hayes-Lattin; J. Gajewski; A. Dunn; C. Jacoby; S. Slater; B. Allen; R. Maziarz

Book ID: 116281583
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 48 KB
Volume: 16
Category: Article
ISSN: 1083-8791
DOI: 10.1016/j.bbmt.2009.12.384

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Comparative outcomes of reduced intensit

Comparative outcomes of reduced intensity and myeloablative allogeneic hematopoietic stem cell transplantation in patients under 50 with hematologic malignancies

✍ Inho Kim; Sung Soo Yoon; Kyung-Hun Lee; Bhumsuk Keam; Tae Min Kim; Jin-Soo Kim; 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 138 KB

323: Chronic Graft Versus Host Disease a

323: Chronic Graft Versus Host Disease and Pretransplant Disease Status Predict Outcomes in Patients with Hematologic Malignancies Undergoing Reduced Intensity Allogeneic Stem Cell Transplantation

✍ M. Shah; M. Agha; M. Mapara; K. Lenhart; A. Raptis 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 68 KB

Reduced Intensity Conditioning (RIC) Wit

Reduced Intensity Conditioning (RIC) With FLU-BU-ATG And Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) From HLA Identical Donors: Relapse-Free Survival (RFS) Of 42% In Pediatric Patients With High-Risk Hematologic Malignancies

✍ R.E. Duerst; D.A. Jacobsohn; J. Schneiderman; S. Chaudhury; W. Tse; M. Kletzel 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 83 KB

CD34+ Cell Dose and Full Donor Chimerism

CD34+ Cell Dose and Full Donor Chimerism at Day +100 Is Associated with Survival in Patients Who Received Reduced-Intensity Conditioning (RIC) With Fludarabine/Melphalan Prior To Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) for Hematologic Malignancies

✍ S.G. Holtan; W.J. Hogan; M.A. Elliott; D.A. Gastineau; T.G. Call; S.A. Ansell; D 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 62 KB

Allogeneic Hematopoietic Stem Cell Trans

Allogeneic Hematopoietic Stem Cell Transplantation (SCT) Using Fludarabine/Treosulfan Conditioning Regimen Compared With Busulfan-Based Myeloablative And Reduced-Intensity Conditioning In Patients With AML And MDS; Relative Outcomes Depend On Disease Status At SCT

✍ A. Shimoni; N. Shem-Tov; A. Rand; Y. Volchek; R. Yerushalmi; I. Hardan; A. Nagle 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 51 KB